vanilmandelic acid has been researched along with Day Blindness in 3 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson-Ramcharan, A | 1 |
Khan, J | 1 |
Ping, AC | 1 |
Harnarayan, C | 1 |
Bajaj, NP | 1 |
Morrish, PK | 1 |
Dieckhues, B | 1 |
3 other studies available for vanilmandelic acid and Day Blindness
Article | Year |
---|---|
Extraadrenal retroperitoneal paraganglioma causing malignant hypertension and permanent visual loss in an eleven-year-old girl.
Topics: Child; Female; Humans; Hypertension, Malignant; Paraganglioma; Retroperitoneal Neoplasms; Vanilmande | 2000 |
The danger of ignoring a migraine.
Topics: Adult; Diagnosis, Differential; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Mal | 2002 |
[The influence of ocular perception on the human endocrine system (author's transl)].
Topics: Adult; Aged; Blindness; Cataract Extraction; Catecholamines; Circadian Rhythm; Female; Gonadotropins | 1974 |